NCT04247477

Brief Summary

The aim of the this study is to assess the short term physiological effects of 3 ventilation strategies for adult patients with ARDS admitted to intensive care unit. Two of those strategies are based on electrical impedance tomography (EIT) monitoring.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 21, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 30, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

September 22, 2020

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2021

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

7 months

First QC Date

January 21, 2020

Last Update Submit

July 29, 2022

Conditions

Keywords

ARDSEITPEEP titrationMechanical Ventilation

Outcome Measures

Primary Outcomes (1)

  • Change in PaO2 (mmHg)

    As it is a physiological study, all the outcomes will be analyzed with the same importance!

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

Secondary Outcomes (12)

  • Change in PaCO2 (mmHg)

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

  • Plateau pressure (cmH2O)

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

  • Positive end expiratory pressure (cmH2O)

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

  • Expiratory and inspiratory transpulmonary pressure (cmH2O)

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

  • Regional ventilation distribution (%)

    Time : 0 ; 45 minutes ; 90 minutes ; 135 minutes ; 180 minutes

  • +7 more secondary outcomes

Study Arms (2)

A-B-A-C

EXPERIMENTAL

Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B) - Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C)

Other: Ventilation strategy

A-C-A-B

EXPERIMENTAL

Four consecutive steps (45 min per step) are tested in the following order: Peep titration strategy according to Express method (A) - Peep titration strategy according to estimation of lung inhomogeneity (C) - Peep titration strategy according to Express method (A) - Peep titration strategy according to overdistension and collapse estimation (B)

Other: Ventilation strategy

Interventions

Patients are ventilated in randomized order with three different ventilation strategies (A,B and C)

A-B-A-CA-C-A-B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with moderate to severe ARDS, defined by the Berlin consensus, at 12 to 48h from diagnosis
  • PaO2/FiO2 ratio \< 150 mmHg
  • Patient affiliated to or beneficiary of a health care plan
  • Consent obtained from patient's SDM

You may not qualify if:

  • Pneumothorax
  • Contraindication to the insertion of a nasogastric tube with an esophageal balloon
  • Contraindication to the use of Electrical impedance tomography
  • Pregnancy, lactating or parturient woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Angers

Angers, 49100, France

Location

MeSH Terms

Conditions

Acute Lung Injury

Condition Hierarchy (Ancestors)

Lung InjuryLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: We use a crossover sequential model, with all 3 strategies tested in both arms. A reference strategy, based on the Express method (PEEP level adjusted to reach a plateau pressure of 28-30 cmH2O), is applied at the begining of the study and during a wash-out period (between the 2 periods of application of the 2 EIT-based strategies). The 2 EIT-based strategies are applied in a randomized order.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2020

First Posted

January 30, 2020

Study Start

September 22, 2020

Primary Completion

April 8, 2021

Study Completion

April 8, 2021

Last Updated

August 2, 2022

Record last verified: 2022-07

Locations